{
    "startDate": "2018-01-01",
    "endDate": "2018-12-31",
    "year": "2018",
    "quarter": "FY",
    "symbol": "BIIB",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents, beginning of the year",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 1224600000
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesCurrent",
                "unit": "usd",
                "value": 2313400000
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 1958500000
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "biib:DueFromUnconsolidatedJointBusiness",
                "unit": "usd",
                "value": 526900000
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 929900000
            },
            {
                "label": "Other Assets, Current",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 687600000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 7640900000
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesNoncurrent",
                "unit": "usd",
                "value": 1375900000
            },
            {
                "label": "Total property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 3601200000
            },
            {
                "label": "Intangible assets",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 3120000000
            },
            {
                "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 5706400000
            },
            {
                "label": "Deferred tax asset",
                "concept": "DeferredTaxAssetsLiabilitiesNetNoncurrent",
                "unit": "usd",
                "value": 2153900000
            },
            {
                "label": "Prepaid research and development",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 1690600000
            },
            {
                "label": "Assets transferred, net",
                "concept": "Assets",
                "unit": "usd",
                "value": 25288900000
            },
            {
                "label": "Current portion of notes payable",
                "concept": "DebtCurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Taxes payable",
                "concept": "TaxesPayableCurrent",
                "unit": "usd",
                "value": 63500000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 370500000
            },
            {
                "label": "Accrued expenses and other",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 2861200000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3295200000
            },
            {
                "label": "Current portion:",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 5936500000
            },
            {
                "label": "Deferred tax liability",
                "concept": "DeferredTaxLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1636200000
            },
            {
                "label": "Other Liabilities, Noncurrent",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1389400000
            },
            {
                "label": "Liabilities transferred, net",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 12257300000
            },
            {
                "label": "Commitments and Contingencies Disclosure [Abstract]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, par value $0.001 per share",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock, par value $0.0005 per share",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 100000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Accumulated other comprehensive income (loss), net of tax beginning balance",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -240400000
            },
            {
                "label": "Retained earnings",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": 16257000000
            },
            {
                "label": "Repurchase of common stock, at cost",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 2977100000
            },
            {
                "label": "Beginning Balance",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 13039600000
            },
            {
                "label": "Beginning Balance",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -8000000
            },
            {
                "label": "Beginning Balance",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 13031600000
            },
            {
                "label": "LIABILITIES AND EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 25288900000
            }
        ],
        "cf": [
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 4474000000
            },
            {
                "label": "Depreciation, amortization and impairments",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 1016600000
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 112500000
            },
            {
                "label": "Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 157500000
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 108300000
            },
            {
                "label": "Contingent Consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 12300000
            },
            {
                "label": "Other",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": 69100000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 205200000
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "IncreaseDecreaseInOtherOperatingCapitalNet",
                "unit": "usd",
                "value": -5700000
            },
            {
                "label": "Inventory",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 52100000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 119100000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 465500000
            },
            {
                "label": "Income tax assets and liabilities",
                "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
                "unit": "usd",
                "value": 321700000
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": -16300000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 6187700000
            },
            {
                "label": "Proceeds from maturities and sales",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 9173700000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecurities",
                "unit": "usd",
                "value": 7694800000
            },
            {
                "label": "Contingent consideration related to Fumapharm AG acquisition",
                "concept": "PaymentsToAcquireOtherProductiveAssets",
                "unit": "usd",
                "value": 1500000000
            },
            {
                "label": "Payments to Acquire in Process Research and Development",
                "concept": "PaymentsToAcquireInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": 112500000
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 770600000
            },
            {
                "label": "Acquisitions of intangible assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 3000000
            },
            {
                "label": "Payments to Acquire Other Investments",
                "concept": "PaymentsToAcquireOtherInvestments",
                "unit": "usd",
                "value": 462900000
            },
            {
                "label": "Payments to Acquire Equity Method Investments",
                "concept": "PaymentsToAcquireEquityMethodInvestments",
                "unit": "usd",
                "value": 676600000
            },
            {
                "label": "Other",
                "concept": "PaymentsForProceedsFromOtherInvestingActivities",
                "unit": "usd",
                "value": -400000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -2046300000
            },
            {
                "label": "Payments for repurchase of common stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": 4352600000
            },
            {
                "label": "Payments related to issuance of stock for share-based compensation arrangements, net",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 2100000
            },
            {
                "label": "Payment to Neurimmune",
                "concept": "PaymentsToMinorityShareholders",
                "unit": "usd",
                "value": 36400000
            },
            {
                "label": "Repayments of borrowings",
                "concept": "RepaymentsOfDebt",
                "unit": "usd",
                "value": 3200000
            },
            {
                "label": "Net cash contribution to Bioverativ, Inc.",
                "concept": "PaymentsOfCapitalDistribution",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Contingent consideration payments",
                "concept": "PaymentsToAcquireProductiveAssets",
                "unit": "usd",
                "value": 58200000
            },
            {
                "label": "Other",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": -19500000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -4472000000
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": -330600000
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": -18600000
            }
        ],
        "ic": [
            {
                "label": "Net income attributable to Biogen Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 4430700000
            },
            {
                "label": "Unrealized gains (losses) recognized during the period, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -10600000
            },
            {
                "label": "Less: reclassification adjustment for (gains) losses included in net income, net of tax",
                "concept": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
                "unit": "usd",
                "value": -6700000
            },
            {
                "label": "Unrealized gains (losses) on securities available for sale, net of tax",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": -3900000
            },
            {
                "label": "Unrealized gains (losses) recognized during the period, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 97400000
            },
            {
                "label": "Less: reclassification adjustment for (gains) losses included in net income, net of tax",
                "concept": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
                "unit": "usd",
                "value": -41800000
            },
            {
                "label": "Unrealized gains (losses) on cash flow hedges, net of tax",
                "concept": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
                "unit": "usd",
                "value": 139200000
            },
            {
                "label": "Gains (Losses) on net investment hedge recognized during period",
                "concept": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax",
                "unit": "usd",
                "value": 5000000
            },
            {
                "label": "Less: Reclassification of net investment hedge forward points amortization",
                "concept": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax",
                "unit": "usd",
                "value": 1500000
            },
            {
                "label": "Gains (losses) on net investment hedges",
                "concept": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax",
                "unit": "usd",
                "value": 3500000
            },
            {
                "label": "Unrealized gains (losses) on pension benefit obligation, net of tax",
                "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
                "unit": "usd",
                "value": -5500000
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -67800000
            },
            {
                "label": "Other comprehensive income:",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 76500000
            },
            {
                "label": "Comprehensive income attributable to Biogen Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 4507200000
            },
            {
                "label": "Comprehensive income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 42900000
            },
            {
                "label": "Comprehensive income",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 4550100000
            },
            {
                "label": "Product Revenues",
                "concept": "Revenues",
                "unit": "usd",
                "value": 13452900000
            },
            {
                "label": "Cost of Sales",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 1816300000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 2597200000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2106300000
            },
            {
                "label": "Amortization and impairment of acquired intangible assets",
                "concept": "biib:AmortizationandImpairmentofAcquiredIntangibleAssets",
                "unit": "usd",
                "value": 747300000
            },
            {
                "label": "Collaboration profit (loss) sharing",
                "concept": "biib:CollaborationProfitSharing",
                "unit": "usd",
                "value": 185000000
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 112500000
            },
            {
                "label": "Restructuring charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 12000000
            },
            {
                "label": "Contingent Consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 12300000
            },
            {
                "label": "TECFIDERA litigation settlement charge",
                "concept": "LitigationSettlementExpense",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Costs and expenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 7564300000
            },
            {
                "label": "Income from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 5888600000
            },
            {
                "label": "Nonoperating Income (Expense)",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 11000000
            },
            {
                "label": "Income before income tax expense and equity in loss of investee, net of tax",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 5899600000
            },
            {
                "label": "Income tax benefit (expense)",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 1425600000
            },
            {
                "label": "Equity in loss of investee, net of tax",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 4474000000
            },
            {
                "label": "Net income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 43300000
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 21.63
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 21.58
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 204900000
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 205300000
            }
        ]
    }
}